The complex and dual role of TGF-β as both a tumor suppressor and tumor promoter [21] underscores the potential risk associated with inhibiting the physiological effects of TGF-β, while there is an urgent need to interfere with its tumor-promoting effects [20,22]. The gene discussed is TGFB1; the disease is neoplasm.